Days Inventory is also known as Days Sales of Inventory (DSI). Nektar Therapeutics's Average Total Inventories for the
three
months ended in Dec. 2023 was $15.62 Mil. Nektar Therapeutics's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $7.28 Mil.
Hence, Nektar Therapeutics's Days Inventory for the
three
months ended in Dec. 2023 was 195.65.
The historical rank and industry rank for Nektar Therapeutics's Days Inventory or its related term are showing as below:
NKTR'
s Days Inventory Range Over the Past 10 Years
Min: 130.03 Med: 179.84 Max: 295.26
Current: 197.5
During the past 13 years, Nektar Therapeutics's highest Days Inventory was 295.26. The lowest was 130.03. And the median was 179.84.
NKTR's Days Inventory is ranked worse than 51.46% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs NKTR: 197.50
Nektar Therapeutics's Days Inventory
declined
from Dec. 2022 (280.05) to Dec. 2023 (195.65).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nektar Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nektar Therapeutics's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.65.
Nektar Therapeutics Days Inventory Historical Data
The historical data trend for Nektar Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nektar Therapeutics's Days Inventory
For the Biotechnology subindustry, Nektar Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nektar Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nektar Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nektar Therapeutics's Days Inventory falls into.
Nektar Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Nektar Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nektar Therapeutics (NAS:NKTR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nektar Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nektar Therapeutics's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nektar Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of Nektar Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Nektar Therapeutics (Nektar Therapeutics) Business Description
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, the company is focused on activating the immune system's natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NKTR has been successfully added to your 